相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Device-handling study of a novel breath-actuated inhaler, Synchrobreathe (R), versus a pMDI
Santhalingam Balamurugan et al.
RESPIRATORY MEDICINE (2020)
Real-world evaluation of the clinical safety and efficacy of fluticasone/formoterol FDC via the Revolizer® in patients with persistent asthma in India
Aloke Ghoshal et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2020)
Comparison of fluticasone/formoterol with budesonide/formoterol pMDI in adults with moderate to severe persistent asthma: Results from a 12-week randomized controlled trial
Akash Balki et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2018)
Efficacy and safety of fluticasone propionate/formoterol fumarate in pediatric asthma patients: a randomized controlled trial
Anna Ploszczuk et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2018)
Real-life effectiveness of asthma treatment with a fixed-dose fluticasone/formoterol pressurised metered-dose inhaler Results from a non-interventional study
O. Schmidt et al.
RESPIRATORY MEDICINE (2017)
Initiating or changing to a fixed-dose combination of Fluticasone propionate/Formoterol over Fluticasone propionate/Salmeterol: A real-life effectiveness and cost impact evaluation
Simon Wan Yau Ming et al.
RESPIRATORY MEDICINE (2017)
Fluticasone propionate/formoterol for COPD management: a randomized controlled trial
A. Papi et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2017)
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report
Claus F. Vogelmeier et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
A 12-week open-label, randomized, controlled trial and 24-week extension to assess the efficacy and safety of fluticasone propionate/formoterol in children with asthma
Andrzej Emeryk et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2016)
Inhaled corticosteroids: potency, dose equivalence and therapeutic index
Peter T. Daley-Yates
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Fluticasone-formoterol: a systematic review of its potential role in the treatment of asthma
Theresa R. Prosser et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2015)
Inhaled corticosteroids in COPD: the clinical evidence
Pierre Ernst et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Efficacy and safety of the single-capsule combination of fluticasone/formoterol in patients with persistent asthma: a non-inferiority trial
Marti Antilla et al.
JORNAL BRASILEIRO DE PNEUMOLOGIA (2014)
Clinical utility and development of the fluticasone/formoterol combination formulation (Flutiform®) for the treatment of asthma
Jonathan Corren et al.
Drug Design Development and Therapy (2014)
Fluticasone/Formoterol Combination Therapy Compared With Monotherapy in Adolescent and Adult Patients With Mild to Moderate Asthma
David S. Pearlman et al.
CLINICAL THERAPEUTICS (2013)
Superiority of fluticasone propionate/formoterol fumarate versus fluticasone propionate alone in patients with moderate-to-severe asthma: a randomised controlled trial
Tetyana Pertseva et al.
CURRENT MEDICAL RESEARCH AND OPINION (2013)
Efficacy and safety profile of fluticasone/formoterol combination therapy compared to its individual components administered concurrently in asthma: a randomised controlled trial
Anna Bodzenta-Lukaszyk et al.
CURRENT MEDICAL RESEARCH AND OPINION (2013)
Fluticasone Propionate/Formoterol Fumarate: A Review of Its Use in Persistent Asthma
Kate McKeage
DRUGS (2013)
Fluticasone/formoterol dry powder versus budesonide/formoterol in adults and adolescents with uncontrolled or partly controlled asthma
A. Cukier et al.
RESPIRATORY MEDICINE (2013)
Efficacy and safety of fluticasone/formoterol combination therapy in patients with moderate-to-severe asthma
Jonathan Corren et al.
RESPIRATORY MEDICINE (2013)
Onset of Bronchodilation with Fluticasone/Formoterol Combination Versus Fluticasone/Salmeterol in an Open-Label, Randomized Study
Rene Aalbers et al.
ADVANCES IN THERAPY (2012)
Nongenomic Effects of Fluticasone Propionate and Budesonide on Human Airway Anion Secretion
Takefumi Mizutani et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2012)
Fluticasone/Formoterol Combination Therapy versus Budesonide/Formoterol for the Treatment of Asthma: A Randomized, Controlled, Non-Inferiority Trial of Efficacy and Safety
Anna Bodzenta-Lukaszyk et al.
JOURNAL OF ASTHMA (2012)
Safety and efficacy of fluticasone/formoterol combination therapy in adolescent and adult patients with mild-to-moderate asthma: a randomised controlled trial
Robert A. Nathan et al.
BMC PULMONARY MEDICINE (2012)
Efficacy and safety of fluticasone and formoterol in a single pressurized metered dose inhaler
Anna Bodzenta-Lukaszyk et al.
RESPIRATORY MEDICINE (2011)
Fluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatment of asthma, but has a more rapid onset of action: an open-label, randomized study
Anna Bodzenta-Lukaszyk et al.
BMC PULMONARY MEDICINE (2011)
Systemic exposure to fluticasone propionate administered via metered-dose inhaler containing chlorofluorocarbon or hydrofluoroalkane propellant
AE Mackie et al.
CLINICAL PHARMACOKINETICS (2000)
分享论文
